J Korean Med Assoc Search

CLOSE


J Korean Med Assoc > Volume 47(10); 2004 > Article
Shin: Chronic Fatigue Syndrome : An Overview

Abstract

Fatigue is probably the most common symptom from both acute and chronic illnesses. It can be defined as a pervasive sense of tiredness or lack of energy that may not be related to exertion. Fatigue is transitory in most cases, however, if it is prolonged or disabling, a significant problem such as chronic fatigue syndrome (CFS) may be warranted. CFS is a complex, debilitating disorder characterized by severe persistent or relapsing fatigue for at least 6 months and a group of characteristic but nonspecific symptoms. Many researchers have proposed that CFS has a specific underlying cause. Currently, however, there is no evidence that supports this view. In addition, since there is no specific physical findings or definitive laboratory tests for consistent biological markers, the diagnosis of CFS depends on operational criteria that do not afford validity and is primarily a diagnosis by exclusion. The prognosis is poor and often the disability and impairment of daily function and performance may be prolonged. The limited understanding of CFS has complicated the management of this disorder. Therefore, the treatment of CFS may be variable and should be tailored to each patient-it should include exercise, diet, good sleep hygiene, antidepressants, and other medications, depending on the patient's clinical presentation.

References

1. Matthews DA, Manus P, Lane TJ. Evaluation and management of patients with chronic fatigue. Am J Med Sci 1991;302:269-277.

2. Epstein KR. The chronically fatigued patient. Medical Clinics of North America 1995;79:315-327.

3. Wessely S, Hotopf M, Sharpe M. Chronic fatigue and its syndrome 1998;Oxford ; New York: Oxford University Press.

4. Straus SE. History of chronic fatigue syndrome. Rev Infect Dis 1991;13:S2-S7.

5. Buchwald D, Sullivan JL, Komaroff AL. Frequency of 'chronic active Epstein-Barr virus infection' in a general medical practice. JAMA 1987;257:2303-2307.

6. Jones JF, Ray CG, Minnich LL, Hicks MJ, Kibler R, Lucas DO. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med 1985;102:1-7.

7. Holmes GP, Kaplan JE, Gantz NM, et al. Chronic Fatigue Syndrome: a working case definition. Ann Intern Med 1988;108:387-389.

8. Fukuda K, Straus SE, Hickie I, et al. The Chronic Fatigue Syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994;121:953-959.

9. Carruthers BM, Jain AK, Meirleir KL, Peterson DL, Klimas NG, et al. Myalgic encephalomyelitis/Chronic fatigue syndrome: Clinical working case definition, diagnostic and treatment protocols. Journal of Chronic Fatigue Syndrome 2003;11:7-115.

10. Lloid AR. Chronic fatigue and chronic fatigue syndrome: Shifting boundaries and attributions. Am J Med 1998;105:7S-10S.

11. David A, Pelosi A, McDonald E, et al. Tired, weak, or in need of rest: fatigue among general practice attenders. BMJ 1990;301:1199-1202.

13. Jason LA, Richman JA, Rademaker AW, et al. A community-based study of chronic fatigue syndrome. Arch Intern Med 1999;159:2129-2137.

14. Wessely S, Chalder T, Hirsch S, Wallace P, Wright D. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health 1997;87:1449-1455.

16. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994;38:383-392.

17. Reyes M, Dobbins JG, Nisenbaum R, Subedar NS, Randall B, Reeves WC. Chronic fatigue syndrome progression and self-defined recovery: evidence from the CDC surveillance system. J Chronic Fatigue Syndr 1999;5:7-17.

18. Russo J, Katon W, Clark M, Kith P, Sintay M, Buchwald D. Longitudinal changes associated with improvement in chronic fatigue patients. J Psychosom Res 1998;45:67-76.

19. Klonoff DC. Chronic fatigue syndrome. Clin Infect Dis 1992;15:812-823.

20. CDC. Chronic fatigue syndrome 1998;Atlanta U.S.: DHHS.

21. Powell R, Dolan R, Wessely S. Attributions of self-esteem in depression and chronic fatigue syndromes. J Psychosom Res 1990;34:665-673.

22. Demitrack MA, Dale JK, Straus SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991;73:1224-1234.

23. Sharpe M, Clements A, Hawton K, et al. Increased prolactin response to buspirone in chronic fatigue syndrome. J Affect Disord 1996;41:71-76.

24. Komaroff AL, Fagioli LR, Doolittle TH, et al. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med 1996;101:281-290.

25. Jason LA, Richman JA, Friedberg F, Wagner L. Politics, science, and the emergence of a new disease: The case of chronic fatigue syndrome. Am Psychol 1997;52:973-983.

26. Evengard B, Schacterle RS, Komaroff AL. Chronic fatigue syndrome : new insights and old ignorance. J Intern Med 1999;246:455-469.

27. Johnson SK, Deluca J, Fiedler N, et al. Cognitive functioning of patients with chronic fatigue syndrome. Clin Infect Dis 1994;18:Suppl 1. S84-S85.

28. Freeman R, Komaroff AL. Does the chronic fatigue syndrome involve the autonomic nervous system? Am J Med 1997;102:357-362.

29. Landay AL, Jessop C, Lennette ET, et al. Chronic fatigue syndrome : clinical condition associated with immune activation. Lancet 1991;338:707-712.

30. Barker E, Fujimura SF, Fadem MB, et al. Immunologic abnormalities associated with chronic fatigue syndrome. Clin Infect Dis 1994;18:Suppl 1. S136-S141.

31. Patnaik M, Komaroff AL, Conley E, et al. Prevalence to IgM antibodies to human herpes virus 6 early antigen(p41/38) in patients with chronic fatigue syndrome. J Infect Dis 1995;172:1364-1367.

32. Dobbins JG, Lipkin WI, Even C, et al. Borna disease virus in the Atlanta CFS case-control study. J Chron Fatigue Syn 1996;2:82-83.

33. Suhadolnik RJ, Reichenbach NL, Hitzges P, et al. Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis 1994;18:Suppl 1. S96-S104.

34. Suhadolnik RJ, Peterson DL, O'Brien K, et al. Further evidence for biochemical defects in the 2-5A synthetase/RNase L and PKR pathway in chronic fatigue syndrome. J Chron Fatigue Syn 1996;2:123.

35. Suhadolnik RJ, Peterson DL, O'Brien K, et al. Biochemical evidence for a novel molecular weight 2-5A dependent RNase L in chronic fatigue syndrome. J Interferon Cytokine Res 1997;17:377-385.

36. Komaroff AL. The biology of chronic fatigue syndrome. Am J Med 2000;108:169-171.

37. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res 1993;17:147-153.

38. NIAID. Chronic fatigue syndrome. Information for physicians 1996;Atlanta U.S.: DHHS.

39. Fulcher KY, White PD. Randomized controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ 1996;314:1647-1652.

40. Depart of Health(UK). A report of the CFS/ME working group : Report to the Chief Medical Officer of an independent working group 2002.

41. AHRQ Publication No. 02-E001. Evidence report/technology assessment No. 42 : Defining and managing chronic fatigue syndrome 2001.

42. Bagnall AM, Whiting P, Wright K, Sowden AJ. The effectiveness of interventions used in the treatment/management of chronic fatigue syndrome and/or myalgic encephalomyelitis in adults and children. The NHS Centre for Reviews and Dissemination 2001;New York: University of York.

43. Whiting P, Bagnall AM, Sowden AJ, Cornell JE, Mulrow CD, Ramirez G. Interventions for the treatment and management of chronic fatigue syndrome: A systematic review. JAMA 2001;286:1360-1368.

44. Veterans Health Administration, Depart of Defence. VHA/DoD clinical practice guideline for the management of medical unexplained symptoms : chronic pain and fatigue Version 1.0 2002.

Figure 1
jkma-47-983-g001-l.jpg
Figure 2
jkma-47-983-g002-l.jpg
Figure 3
jkma-47-983-g003-l.jpg
Figure 4
jkma-47-983-g004-l.jpg
Table 1
jkma-47-983-i001-l.jpg
Table 2
jkma-47-983-i002-l.jpg
Table 3
jkma-47-983-i003-l.jpg
Table 4
jkma-47-983-i004-l.jpg


ABOUT
ARTICLE CATEGORY

Browse all articles >

ARCHIVES
FOR CONTRIBUTORS
Editorial Office
37 Ichon-ro 46-gil, Yongsan-gu, Seoul
Tel: +82-2-6350-6562    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2024 by Korean Medical Association.

Developed in M2PI

Close layer
prev next